Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts. - Wikidata - awgldk - TriplyDB

Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts.

Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts.

http://www.wikidata.org/entity/Q45287212

about

Clinical significance of donor-specific human leukocyte antigen antibodies in liver transplantation Factors influencing long-term outcome after kidney transplantation The use of novel diagnostics to individualize immunosuppression following transplantation MHC class I signaling: new functional perspectives for an old molecule Immune response to an adjuvanted influenza A H1N1 vaccine (Pandemrix(®)) in renal transplant recipients.Influenza A/H1N1 vaccine in patients treated by kidney transplant or dialysis: a cohort study Poor seroprotection but allosensitization after adjuvanted pandemic influenza H1N1 vaccine in kidney transplant recipients.Bortezomib in kidney transplant recipients with antibody mediated rejection: three case reports Molecules Great and Small: The Complement System.Posttransplant allosensitization in low immunological risk kidney and kidney-pancreas graft recipients Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial Intravenous immunoglobulin therapy in kidney transplant recipients with de novo DSA: Results of an observational study.Impact of maintenance immunosuppressive regimens--balance between graft protective suppression of immune functions and a near physiological immune response.An adjustable predictive score of graft survival in kidney transplant patients and the levels of risk linked to de novo donor-specific anti-HLA antibodies Antithymocyte globulin is associated with a lower incidence of de novo donor-specific antibodies in moderately sensitized renal transplant recipients Clinical outcomes among renal transplant recipients with pre-transplant weakly reactive donor-specific antibodies Differences in immunogenicity of HLA antigens and the impact of cross-reactivity on the humoral response.De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients.Surveillance of alloantibodies after transplantation identifies the risk of chronic rejection.The impact of pretransplant donor-specific antibodies on graft outcome in renal transplantation: a six-year follow-up study.The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.Germinal center alloantibody responses are mediated exclusively by indirect-pathway CD4 T follicular helper cells.Donor-specific antibodies after ceasing immunosuppressive therapy, with or without an allograft nephrectomy De Novo Donor-Specific HLA Antibody Development and Peripheral CD4(+)CD25(high) Cells in Kidney Transplant Recipients: A Place for Interaction?Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study.Blockade of p-selectin is sufficient to reduce MHC I antibody-elicited monocyte recruitment in vitro and in vivo.Clinical Significance of HLA-DQ Antibodies in the Development of Chronic Antibody-Mediated Rejection and Allograft Failure in Kidney Transplant Recipients.Involvement of indirectly allostimulated CD4+CD43highCD45RO+ T cell proliferation in the development of chronic allograft nephropathy Incidence and clinical significance of de novo donor specific antibodies after kidney transplantation.HLA class I antibody-mediated endothelial and smooth muscle cell activation.Can a combined screening/treatment programme prevent premature failure of renal transplants due to chronic rejection in patients with HLA antibodies: study protocol for the multicentre randomised controlled OuTSMART trial.Graft dysfunction in chronic antibody-mediated rejection correlates with B-cell-dependent indirect antidonor alloresponses and autocrine regulation of interferon-γ production by Th1 cells.Detecting adaptive immunity: applications in transplantation monitoring.Application of Operational Tolerance Signatures Are Limited by Variability and Type of Immunosuppression in Renal Transplant Recipients: A Cross-Sectional Study.Barriers to successful transplantation of the sensitized patient.Monitoring tolerance and rejection in organ transplant recipients.Biomarkers in solid organ transplantation.Strategies for B-lymphocyte repertoire remodeling in transplantation tolerance.Immunologic monitoring in transplantation revisited.Detection of anti-HLA antibodies by solid-phase assay in kidney transplantation: friend or foe?

P2860

Q26780271-CD9E08E2-DDD8-49D6-A063-56ADD0EF1816 Q26825480-11588734-DBEC-476A-ABC2-5B68B5B2F3DD Q26864686-B1F20846-BF2F-4350-A25F-5891955BCC44 Q27000194-EDC90610-45CC-4AFB-9C69-10ED90466528 Q30403135-DA984636-5E98-4E8F-B8A0-3637660032E8 Q30407134-CAF78B74-D044-459F-916F-0795B0AF9D85 Q30421507-2CF95327-AFC3-4E9A-B6A6-3150C7F7D736 Q33389918-85A66EC3-DA7F-4620-B21E-E652C86B4FC4 Q33419651-EB8B0522-B017-4C85-BEF7-07448FBCF170 Q33563056-6776D3E2-81EE-4155-BA10-639ACC00CCE1 Q33584895-F304953A-B6C7-48F6-8DDD-203CB8A8F93D Q33842250-984E9C92-D9A6-492D-819E-FCB4C71D9047 Q33845320-D14DB79F-B37B-4AB9-8823-1E58C86725F9 Q33865743-BEE6E580-7D3A-4D8D-A75B-84C1B2C9AC86 Q33930084-BE1215AB-CE75-4FFB-B20D-4B00ED516233 Q34080938-69755221-6BC1-4645-B1BA-0410D4D2E469 Q34796926-27F021D6-B0C9-435C-83C4-77AB397D5606 Q35535173-7D3E5F7D-DC4E-48F7-8E22-EC4B0AFF7D21 Q35669313-EA1AE14A-5772-4AB5-86B6-F0B162F397FA Q35865046-89974F9A-8D58-482E-8E26-D6E580A07380 Q35975914-A9E8AE2A-B842-4E51-B197-32FF6D33A3FE Q36043667-0D13F9C5-0A0A-40EB-9F84-98EA04709EDF Q36126873-7A519D5D-505A-4F76-B091-7C759A009ADA Q36204503-74D090B3-3C46-4543-BFF8-3FC01EE055BA Q36246918-297F54CE-55D9-4AB1-9EE9-1522FE625CDB Q36584512-4928E820-6325-449A-96A5-75EA270AEB5D Q36822826-D1938A75-3982-4113-BD88-0A06B33D8013 Q37107014-DFB04D38-4206-4C9A-BD4E-9D536DBE9AA3 Q37375622-620030FB-89CE-420B-95D8-C22E08FAD35F Q37430871-DB44AE45-88F0-44FD-8812-679330527908 Q37529483-2985D668-B550-4797-872E-F8232F7D9C9B Q37601515-CE6DECEB-7408-4A14-BDCC-D0D35FDC2F48 Q37685073-0D4D7BFA-9031-4BB4-84A2-DA710D47D1B9 Q37715369-76B14ED4-7CA1-4F04-BB90-9F6E064B9900 Q37742103-192F8162-EBA2-4AA6-8B86-67257458B270 Q37894733-043C4B15-9888-44A0-95E7-D81F4B068760 Q37902869-603E8618-2873-4BB3-A4C1-69DD7CEE0BC6 Q37938922-4BD64F87-48E6-41BF-9786-EB9E550BC85B Q37970214-D07E6F7C-901C-4A4B-AC9D-3BE4CCEA757B Q38001495-51770DE2-9A4C-4F32-A298-902AB3B2CD21

P2860

Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts.

http://www.wikidata.org/entity/Q45287212

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Anti-human leukocyte antigen a ...... rejection of renal allografts.

@en

Anti-human leukocyte antigen a ...... rejection of renal allografts.

@nl

type

label

Anti-human leukocyte antigen a ...... rejection of renal allografts.

@en

Anti-human leukocyte antigen a ...... rejection of renal allografts.

@nl

prefLabel

Anti-human leukocyte antigen a ...... rejection of renal allografts.

@en

Anti-human leukocyte antigen a ...... rejection of renal allografts.

@nl

P1433

Q45287212-74AC22E3-7FE5-4F66-95E4-3D701A1A5785

P1476

Q45287212-CC15AAD8-B9A1-4894-B432-D5567A908433

P2093

Q45287212-026EED4E-232B-482B-AE98-6BE92F55FB05

Q45287212-2401D855-5568-47B2-A690-1CBAD2973080

Q45287212-43E05AD6-B8F2-4E5F-9952-492305FC11CE

Q45287212-64D68BD7-E2B8-4C8F-ADBF-3ABD6C3F7F11

Q45287212-718CF90B-B950-4A86-A4A6-FD94E43BF3C7

Q45287212-A2520AC4-6248-4B18-9C75-84EACBC32542

Q45287212-B500EC4E-FBD8-4620-BD0B-E99CFFF34DAD

Q45287212-D8C7B65E-A0B4-47E3-9487-CFAFD3365835

Q45287212-E96008F3-A871-4EE4-9AEB-9EBB62C26751

P304

Q45287212-67778263-5E15-47A2-9ED2-4A8523CE8DDE

P31

Q45287212-473BC950-3EBB-4289-AECB-F7D4B8CA62B5

P356

Q45287212-94B6BE83-397C-40E3-936F-4FD4AA41A40D

P433

Q45287212-DBAD678F-C020-4501-AEB6-F79D673B4F3D

P478

Q45287212-F268282B-648B-4315-8809-94E320FE5671

P50

Q45287212-25E6B24A-D12B-4DFC-A8B6-1D60CE5B9E74

Q45287212-31C1C326-0067-4B1C-87FA-A45524017D4D

P577

Q45287212-982406DD-6513-4114-AABA-4E98550936F2

P698

Q45287212-F3712AAB-EF99-48F2-9F10-9DD33C580A43

P921

Q45287212-1D03E2F0-D7AF-46A3-9370-1F3080FCA3ED

Q45287212-246160D7-5998-4AFA-87B8-388A1B3D2B18

P356

TP.0B013E3181A44206

P1433

Transplantation

P1476

Anti-human leukocyte antigen a ...... rejection of renal allografts.

@en

P2093

Abdulgabar Salama

http://www.w3.org/2001/XMLSchema#string

Andreas Kahl

http://www.w3.org/2001/XMLSchema#string

Birgit Rudolph

http://www.w3.org/2001/XMLSchema#string

Constanze Schönemann

http://www.w3.org/2001/XMLSchema#string

Danilo Schmidt

http://www.w3.org/2001/XMLSchema#string

Klemens Budde

http://www.w3.org/2001/XMLSchema#string

Lutz Liefeldt

http://www.w3.org/2001/XMLSchema#string

Nils Lachmann

http://www.w3.org/2001/XMLSchema#string

Paul I Terasaki

http://www.w3.org/2001/XMLSchema#string

P304

1505-1513

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/TP.0B013E3181A44206

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

87

http://www.w3.org/2001/XMLSchema#string

P50

Johann Pratschke

P577

2009-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19461487

http://www.w3.org/2001/XMLSchema#string

P921